In human RA, inhibition of pro-inflammatory cytokines such as IL-1β [24], [25] and notably TNF-α [13], [26] has proven effective in modifying disease and has profoundly improved the quality of life for some patients with severe RA. Here, IL1B is linked to rheumatoid arthritis.